期刊文献+

可调控表达甲型流感病毒M2蛋白的哺乳动物细胞系的建立与鉴定 被引量:5

Establishment of a stable and inducible mammalian cell line expressing influenza virus A M2 protein
原文传递
导出
摘要 甲型流感病毒M2蛋白是一种具有离子通道功能的跨膜蛋白,其氨基酸序列非常保守,可用于流感通用疫苗的研究。为了构建可调控的稳定表达甲型流感病毒M2蛋白的哺乳动物细胞系,首先应用PCR方法从含有流感病毒PR8株第七节段全长基因的质粒中扩增得到M2基因。将该片段亚克隆到真核表达载体pcDNA5/FRT/TO上,用BamHⅠ和NotⅠ双酶切鉴定正确后将重组质粒与表达Flp重组酶的pOG44质粒共转染Flp-In T-REx-293细胞,使目的基因整合到宿主细胞染色体。筛选具有Hygromycin B抗性的细胞株。在该细胞的培养基中加入四环素以诱导目的基因表达,48 h后通过间接免疫荧光方法检测到M2蛋白的表达。共得到16株高表达M2蛋白的重组细胞株,这些细胞株在传10代后仍能稳定表达目的蛋白。未加四环素诱导的细胞没有检测到M2蛋白,说明四环素调控系统严格控制着目的基因的表达。今后,该细胞系可用于流感病毒M2蛋白的功能研究、流感候选疫苗的免疫学评价以及流感病毒减毒活疫苗的研制。 Matrix protein 2(M2) is an integral tetrameric membrane protein of influenza A virus,which functions as ion channel.M2 sequence has shown remarkable conservation,so there has been growing interest in it as "universal" vaccine.In order to establish a stable 293 cell line that express M2 protein under the control of the tetracycline operator,M2 gene was obtained by PCR amplification from the plasmid containing the segment 7 of influenza A virus strain A/PR/8/34 firstly.The PCR product was cloned into BamH Ⅰ /NotⅠ restriction site of pcDNA5/FRT/TO vector,and cotransfected with pOG44 which express Flp recombinase into Flp-In T-REx-293 cell.Integration of pcDNA5/FRT/TO-M2 into the cell genome at the Flp Recombination 748 ISSN1000-3061 CN11-1998/Q Chin J Biotech May 25,2011 Vol.27 No.5 Target(FRT) site brought the SV40 promoter and the initiation codon in frame with the hygromycin resistance gene.Thus,stable cell lines were selected for hygromycin resistance.The expression of M2 protein from hygromycin-resistant cell was induced by addition of tetracycline into the cell culture media,and then tested by indirect immunofluorescence assay(IFA).16 strains with high expression of M2 were selected.After subculturing for more than ten passages,the cell lines still stably expressed M2 protein.No M2 protein could be detected without tetracycline induction,suggesting that the expression was strictly controlled by tetracycline operator.The cell lines expressing M2 will be useful for further functional studies of M2 protein,detection of immune response against natural structure M2 protein and development of live attenuated influenza virus vaccine with reverse genetics technique.
出处 《生物工程学报》 CAS CSCD 北大核心 2011年第5期747-754,共8页 Chinese Journal of Biotechnology
基金 "艾滋病和病毒性肝炎等重大传染病防治"科技重大专项(No.2009ZX10004-710)资助~~
关键词 甲型流感病毒 基质蛋白2 四环素 哺乳动物细胞系 influenza A virus matrix protein 2 tetracycline mammalian cell line
  • 相关文献

参考文献15

  • 1程小雯,郭元吉.流行性感冒病毒及其实验技术.北京:中国三峡出版社,1997:28.
  • 2Schotsaert M, De Filette M, Fiers W, et al. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines, 2009, 8(4): 499-508.
  • 3Feng JQ, Zhang MX, Mozdzanowska K, et al. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J, 2006, 3: 102-114.
  • 4Mozdzanowska K, Zharikova D, Cudic M, et al. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol J, 2007,4: 118-131.
  • 5De Filette M, Martens W, Roose K, et al. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J Biol Chem, 2008, 283(17): 11382-11387.
  • 6Song HC, Nieto GR, Perez DR. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol, 2007, 81(17): 9238 9248.
  • 7Solorzano A, Ye JQ, Perez DR. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu. J Virol, 2010, 84(9): 4587-4596.
  • 8Steel J, Lowen AC, Pena L, et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol, 2009, 83(4): 1742-1753,.
  • 9McCown MF, Pekosz A. The influenza a virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol, 2005, 79(6): 3595-3605.
  • 10Gritz L, Davies J. Plasmid-encoded Hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in E. coli and S. cerevisiae. Gene, 1983, 25(2/3): 179-188.

共引文献1

同被引文献63

  • 1吴玉章,朱锡华.一种病毒蛋白B细胞表位预测方法的建立[J].科学通报,1994,39(24):2275-2279. 被引量:80
  • 2王彬,唐志芬,齐岩,孙凌霜,王君伟.H9N2禽流感病毒HA2基因重组杆状病毒的表达[J].中国兽医科学,2006,36(5):362-365. 被引量:2
  • 3章金刚,倪道明.生物制品的现状与展望[J].中国输血杂志,2006,19(5):349-351. 被引量:8
  • 4管洁,周育森.禽流感病毒M2蛋白研究进展[J].微生物学免疫学进展,2007,35(2):84-86. 被引量:4
  • 5万春和,刘明.A型流感病毒M2蛋白研究进展[J].动物医学进展,2007,28(7):56-60. 被引量:4
  • 6David A S. Genetics of influenza viruses[J]. Annual Review of Genetics, 2002 (36) : 305- 332.
  • 7De Filette M,Jou W,Birkett A,et al. Universal inlfuenza A vaccine, optimization of M2-based constructs[J]. Virology, 2005,337(1) : 149-161.
  • 8Lee D H,Park J K,Lee Y N,et al. H9N2 avian influenza virus like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals[J]. Vaccine, 2011,29(23) :4003-4007.
  • 9Leser G P, Lamb R A. Influenza virus assembly and budding in raft-derived mierodomains:A quantitative analysis of the surface distribution of HA, NA and M2 proteins[J]. Virology, 2005,342 (2) :215-227.
  • 10Meng S,Yang L,Xu C, et al. Recombinant chicken interferon a inhibits H9N2 avian influenza virus replication in vivo by oral administration[J]. J Interferon Cytokine Res, 2011,31 (7) : 533- 538.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部